Erika Jaqueline Acosta De la Cruz

Ms. Erika Jaqueline Acosta De la Cruz

Autonomous University of Guerrero, Faculty of Chemical Biological Sciences
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
MOMonserrat Olea-Flores
Monserrat Olea-Flores
JCJUAN CARLOS CRUZ
JUAN CARLOS CRUZ
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
ECErika Jaqueline Acosta De la Cruz
Erika Jaqueline Acosta De la Cruz
EGEduardo García-Rodríguez
Eduardo García-Rodríguez
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito
Leptin is a hormone secreted mainly by adipocytes; physiologically, it participates in the control of appetite and energy expenditure. However, it has also been linked to tumor progression in different epithelial cancers. In this review, we describe the effect of leptin on epithelial–mesenchymal transition (EMT) markers in different study models, including in vitro, in vivo, and patient studies and in various types of cancer, including breast, prostate, lung, and ovarian cancer. The different studies report that leptin promotes the expression of mesenchymal markers and a decrease in epithelial markers, in addition to promoting EMT-related processes such as cell migration and invasion and poor prognosis in patients with cancer. Finally, we report that leptin has the greatest biological relevance in EMT and tumor progression in breast, lung, prostate, esophageal, and ovarian cancer. This relationship could be due to the key role played by the enriched tumor microenvironment in adipose tissue. Together, these findings demonstrate that leptin is a key biomolecule that drives EMT and metastasis in cancer.